Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients (POPADIPE)

Centre Hospitalier le Mans

Status

Enrolling

Conditions

Pre-Eclampsia

Obesity

Treatments

Other: Hypocaloric diet

Other: Dissociated diet

Study type

Interventional

Funder types

Other

Identifiers

NCT06067906

CHM-2022/S08/12

Details and patient eligibility

About

In view of the known link between pre-eclampsia, overweight/obesity and chronic kidney disease, the aim is to offer for obese and overweight patients to reduce their BMI without reducing lean body mass.

The POPADIPE project will make it possible to limit overweight or obesity by means of nutritional management chosen by the patient (hypocaloric or a dissociated diet). The latter has been the subject of little scientific investigation, particularly in relation to the management of post-pre-eclampsia.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Person affiliated to social security
Free, informed and written consent signed by the participant and the investigator (no later than the day of day of inclusion and before any examination required by the research)
Patient over 18 years of age at the time of inclusion and < 45 years of age
Having had an pre-eclampsia in the last 5 years according to the definitions of the ISSHP 2018
Patient with a BMI between 25 kg/m² and 40 kg/m² who accepts dietetic follow up
Patient with a medical prescription for dietetic follow-up aimed at losing weight loss
Patient with a balanced diet

Exclusion criteria

Patients with a mental disability or language barrier that prevents them from understanding or consenting to the study
Patients deprived of their liberty by judicial or administrative decision
Patients under psychiatric care
Patients subject to a legal protection measure
Patients with cognitive disorders or defined eating disorders
Patients who are pregnant or breast-feeding
Patients undergoing steroid treatment and/or immunosuppression
Have been on a low-calorie or dissociated diet for at least 6 months
Patients with CKD stage ≥ 3A